Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Notes:
Sample sizes (n) refer to the number of respondents for the 15 to 24 years age group. For number of respondents for the whole surveys see epidemiological tables on population surveys in the 2006 statistical bulletin.
Data are from the most recent national surveys available in each country (see epidemiological tables on population surveys, 2006 statistical bulletin).
For young adults, the EMCDDA standard age range is 15 to 34 years (Denmark and UK from 16, Czech Republic, Estonia, Hungary and Germany from 18 years). Variations in age ranges may slightly influence some national differences. In some countries the figures were recalculated at national level, to adapt as far as possible to standard EMCDDA age groups.
Czech Republic: 2004; n=586
Denmark: 2000; n=1754
Germany: 2003; n=1891
Estonia: 2003; n=329
Greece: 2004; n=1785
Spain: 2003; n=2327
France: 2002; n=345
Ireland: 2002/03; n=
Italy: 2003; n=2112
Latvia: 2003; n=
Lithuania: 2004; n=923
Hungary: 2003; n=943
Netherlands: 2001; n=
Austria: 2004; n=959
Poland: 2002; n=
Portugal: 2001; n=3099
Slovakia: 2004; n=307
Finland: 2004; n=494
UK (E&W): 2004/05; n=6287
Bulgaria: 2005; n=173
Norway: 2004; n=645
See also 'General notes for interpreting data' on the Explanatory notes and help page.
Sources:
Reitox national reports (2005), taken from surveys reports or scientific articles.